[1]
Sangar, V.C., Ghongane, B.B. and Chowdhary, A. 2015. POST-MARKETING PASSIVE SURVEILLANCE OFBIVALENT AND QUADRIVALENT HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINES. International Journal of Pharmacy and Pharmaceutical Sciences. 7, 4 (Apr. 2015), 393–397.